Literature DB >> 16809771

BAL1 and BBAP are regulated by a gamma interferon-responsive bidirectional promoter and are overexpressed in diffuse large B-cell lymphomas with a prominent inflammatory infiltrate.

Przemyslaw Juszczynski1, Jeffery L Kutok, Cheng Li, Joydeep Mitra, Ricardo C T Aguiar, Margaret A Shipp.   

Abstract

BAL1 is a transcription modulator that is overexpressed in chemoresistant, diffuse large B-cell lymphomas (DLBCLs). BAL1 complexes with a recently described DELTEX family member termed BBAP. Herein, we characterized BAL1 and BBAP expression in primary DLBCL subtypes defined by their comprehensive transcriptional profiles. BAL1 and BBAP were most abundant in lymphomas with a brisk host inflammatory response, designated host response (HR) tumors. Although these DLBCLs include significant numbers of tumor-infiltrating lymphocytes and interdigitating dendritic cells, BAL1 and BBAP were expressed primarily by malignant B cells, prompting speculation that the genes might be induced by host-derived inflammatory mediators such as gamma interferon (IFN-gamma). In fact, IFN-gamma induced BAL1 and BBAP expression in DLBCL cell lines; doxycycline-induced BAL1 also increased the expression of multiple IFN-stimulated genes, directly implicating BAL1 in an IFN signaling pathway. We show that BAL1 and BBAP are located on chromosome 3q21 in a head-to-head orientation and are regulated by a IFN-gamma-responsive bidirectional promoter. BBAP regulates the subcellular localization of BAL1 by a dynamic shuttling mechanism, highlighting the functional requirement for coordinated BBAP and BAL1 expression. IFN-gamma-induced BAL1/BBAP expression contributes to the molecular signature of HR DLBCLs and highlights the interplay between the inflammatory infiltrate and malignant B cells in these tumors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16809771      PMCID: PMC1592708          DOI: 10.1128/MCB.02351-05

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling.

Authors:  Dimitar Angelov; Annie Molla; Pierre-Yves Perche; Fabienne Hans; Jacques Côté; Saadi Khochbin; Philippe Bouvet; Stefan Dimitrov
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

2.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.

Authors:  George Wright; Bruce Tan; Andreas Rosenwald; Elaine H Hurt; Adrian Wiestner; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

3.  siRNA Selection Server: an automated siRNA oligonucleotide prediction server.

Authors:  Bingbing Yuan; Robert Latek; Markus Hossbach; Thomas Tuschl; Fran Lewitter
Journal:  Nucleic Acids Res       Date:  2004-07-01       Impact factor: 16.971

4.  The BAL-binding protein BBAP and related Deltex family members exhibit ubiquitin-protein isopeptide ligase activity.

Authors:  Kunihiko Takeyama; Ricardo C T Aguiar; Liqun Gu; Chunyan He; Gordon J Freeman; Jeffery L Kutok; Jon C Aster; Margaret A Shipp
Journal:  J Biol Chem       Date:  2003-04-01       Impact factor: 5.157

5.  IFN-gamma protects short-term ovarian carcinoma cell lines from CTL lysis via a CD94/NKG2A-dependent mechanism.

Authors:  Karl-Johan Malmberg; Victor Levitsky; Håkan Norell; Cristina Teixeira de Matos; Mattias Carlsten; Kjell Schedvins; Hodjattallah Rabbani; Alessandro Moretta; Kalle Söderström; Jelena Levitskaya; Rolf Kiessling
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

6.  BAL is a novel risk-related gene in diffuse large B-cell lymphomas that enhances cellular migration.

Authors:  R C Aguiar; Y Yakushijin; S Kharbanda; R Salgia; J A Fletcher; M A Shipp
Journal:  Blood       Date:  2000-12-15       Impact factor: 22.113

7.  ARM domain-dependent nuclear import of adenomatous polyposis coli protein is stimulated by the B56 alpha subunit of protein phosphatase 2A.

Authors:  M A Galea; A Eleftheriou; B R Henderson
Journal:  J Biol Chem       Date:  2001-10-03       Impact factor: 5.157

8.  Interferon-gamma induces p11 gene and protein expression in human epithelial cells through interferon-gamma-activated sequences in the p11 promoter.

Authors:  Xiu-li Huang; Rafal Pawliczak; Xiang-lan Yao; Mark J Cowan; Mark T Gladwin; M J Walter; M J Holtzman; Patricia Madara; Carolea Logun; James H Shelhamer
Journal:  J Biol Chem       Date:  2003-03-14       Impact factor: 5.157

Review 9.  Regulation of tumor suppressors by nuclear-cytoplasmic shuttling.

Authors:  Megan Fabbro; Beric R Henderson
Journal:  Exp Cell Res       Date:  2003-01-15       Impact factor: 3.905

10.  An abundance of bidirectional promoters in the human genome.

Authors:  Nathan D Trinklein; Shelley Force Aldred; Sara J Hartman; Diane I Schroeder; Robert P Otillar; Richard M Myers
Journal:  Genome Res       Date:  2004-01       Impact factor: 9.043

View more
  47 in total

1.  The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma.

Authors:  Przemyslaw Juszczynski; Jing Ouyang; Stefano Monti; Scott J Rodig; Kunihiko Takeyama; Jeremy Abramson; Wen Chen; Jeffery L Kutok; Gabriel A Rabinovich; Margaret A Shipp
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-01       Impact factor: 11.205

2.  Poly(ADP-ribose) regulates post-transcriptional gene regulation in the cytoplasm.

Authors:  Anthony Leung; Tanya Todorova; Yoshinari Ando; Paul Chang
Journal:  RNA Biol       Date:  2012-05-01       Impact factor: 4.652

3.  Transcriptional signature with differential expression of BCL6 target genes accurately identifies BCL6-dependent diffuse large B cell lymphomas.

Authors:  Jose M Polo; Przemyslaw Juszczynski; Stefano Monti; Leandro Cerchietti; Kenny Ye; John M Greally; Margaret Shipp; Ari Melnick
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-20       Impact factor: 11.205

Review 4.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

5.  Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.

Authors:  Chun-Song Yang; Kasey Jividen; Adam Spencer; Natalia Dworak; Li Ni; Luke T Oostdyk; Mandovi Chatterjee; Beata Kuśmider; Brian Reon; Mahmut Parlak; Vera Gorbunova; Tarek Abbas; Erin Jeffery; Nicholas E Sherman; Bryce M Paschal
Journal:  Mol Cell       Date:  2017-05-18       Impact factor: 17.970

6.  BAL1 and its partner E3 ligase, BBAP, link Poly(ADP-ribose) activation, ubiquitylation, and double-strand DNA repair independent of ATM, MDC1, and RNF8.

Authors:  Qingsheng Yan; Rong Xu; Liya Zhu; Xin Cheng; Zhe Wang; John Manis; Margaret A Shipp
Journal:  Mol Cell Biol       Date:  2012-12-10       Impact factor: 4.272

Review 7.  Macro domains as metabolite sensors on chromatin.

Authors:  Melanija Posavec; Gyula Timinszky; Marcus Buschbeck
Journal:  Cell Mol Life Sci       Date:  2013-03-03       Impact factor: 9.261

8.  Complex sense-antisense architecture of TNFAIP1/POLDIP2 on 17q11.2 represents a novel transcriptional structural-functional gene module involved in breast cancer progression.

Authors:  Oleg V Grinchuk; Efthimios Motakis; Vladimir A Kuznetsov
Journal:  BMC Genomics       Date:  2010-02-10       Impact factor: 3.969

9.  FOXO1 is a TXN- and p300-dependent sensor and effector of oxidative stress in diffuse large B-cell lymphomas characterized by increased oxidative metabolism.

Authors:  T Sewastianik; M Szydlowski; E Jablonska; E Bialopiotrowicz; P Kiliszek; P Gorniak; A Polak; M Prochorec-Sobieszek; A Szumera-Cieckiewicz; T S Kaminski; S Markowicz; E Nowak; M A Grygorowicz; K Warzocha; P Juszczynski
Journal:  Oncogene       Date:  2016-05-02       Impact factor: 9.867

10.  BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.

Authors:  Przemyslaw Juszczynski; Linfeng Chen; Evan O'Donnell; Jose M Polo; Stella M Ranuncolo; Riccardo Dalla-Favera; Ari Melnick; Margaret A Shipp
Journal:  Blood       Date:  2009-10-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.